应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MIST Milestone Pharmaceuticals Inc.
盘前交易 07-18 05:24:48 EDT
1.55
-0.10
-6.06%
最高
1.70
最低
1.48
成交量
35.13万
今开
1.69
昨收
1.65
日振幅
13.33%
总市值
8,255万
流通市值
7,673万
总股本
5,326万
成交额
56.02万
换手率
0.71%
流通股本
4,950万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌6.06%报1.55美元
自选股智能写手 · 07-17 22:19
Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌6.06%报1.55美元
Milestone Pharmaceuticals Inc.盘中异动 临近午盘大幅拉升5.36%报1.67美元
自选股智能写手 · 07-16 23:58
Milestone Pharmaceuticals Inc.盘中异动 临近午盘大幅拉升5.36%报1.67美元
Milestone Pharmaceuticals Inc.盘中异动 股价大涨6.62%报1.45美元
自选股智能写手 · 07-10
Milestone Pharmaceuticals Inc.盘中异动 股价大涨6.62%报1.45美元
Milestone Pharmaceuticals Inc.盘中异动 临近午盘快速跳水6.05%报1.55美元
自选股智能写手 · 05-29
Milestone Pharmaceuticals Inc.盘中异动 临近午盘快速跳水6.05%报1.55美元
Milestone Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.30%
自选股智能写手 · 05-06
Milestone Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.30%
Milestone Pharmaceuticals Inc.盘中异动 快速上涨5.03%
自选股智能写手 · 05-01
Milestone Pharmaceuticals Inc.盘中异动 快速上涨5.03%
Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨5.50%报1.62美元
自选股智能写手 · 04-29
Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨5.50%报1.62美元
Milestone Pharmaceuticals Inc.盘中异动 急速上涨5.27%
自选股智能写手 · 04-24
Milestone Pharmaceuticals Inc.盘中异动 急速上涨5.27%
Milestone Pharmaceuticals Inc.盘中异动 下午盘急速下挫5.14%报1.66美元
自选股智能写手 · 04-19
Milestone Pharmaceuticals Inc.盘中异动 下午盘急速下挫5.14%报1.66美元
Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.49%报1.72美元
自选股智能写手 · 04-10
Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.49%报1.72美元
Milestone Pharmaceuticals Inc.盘中异动 下午盘股价大涨5.20%报1.82美元
自选股智能写手 · 03-27
Milestone Pharmaceuticals Inc.盘中异动 下午盘股价大涨5.20%报1.82美元
Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.13%报1.64美元
自选股智能写手 · 03-22
Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.13%报1.64美元
Milestone Pharmaceuticals Inc.2023财年实现净利润-59.69百万美元,同比减少2.23%
自选股智能写手 · 03-22
Milestone Pharmaceuticals Inc.2023财年实现净利润-59.69百万美元,同比减少2.23%
Milestone Pharmaceuticals Inc.盘中异动 急速下跌5.52%
自选股智能写手 · 03-15
Milestone Pharmaceuticals Inc.盘中异动 急速下跌5.52%
Milestone Pharmaceuticals Inc.盘中异动 大幅拉升5.06%
自选股智能写手 · 03-06
Milestone Pharmaceuticals Inc.盘中异动 大幅拉升5.06%
Milestone Pharmaceuticals Inc.股价重挫23.00% 市值跌1262.98万美元
自选股智能写手 · 02-29
Milestone Pharmaceuticals Inc.股价重挫23.00% 市值跌1262.98万美元
Milestone Pharmaceuticals Inc盘中异动 股价大涨5.21%
自选股智能写手 · 02-28
Milestone Pharmaceuticals Inc盘中异动 股价大涨5.21%
Milestone Pharmaceuticals Inc盘中异动 早盘大幅上涨21.76%
自选股智能写手 · 02-26
Milestone Pharmaceuticals Inc盘中异动 早盘大幅上涨21.76%
Milestone Pharmaceuticals Inc盘中异动 早盘急速拉升6.21%报1.59美元
自选股智能写手 · 02-21
Milestone Pharmaceuticals Inc盘中异动 早盘急速拉升6.21%报1.59美元
Milestone Pharmaceuticals Inc盘中异动 快速拉升5.26%
自选股智能写手 · 02-16
Milestone Pharmaceuticals Inc盘中异动 快速拉升5.26%
加载更多
公司概况
公司名称:
Milestone Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Milestone Pharmaceuticals Inc.于2003年根据魁北克省法律注册成立。该公司是一家专注于心血管创新药物开发和商业化的生物制药公司。公司主导候选产品曲立帕米是一种新型强效钙通道阻滞剂,他们将其设计为一种快速起效的鼻腔喷雾剂,供患者自行给药。该公司正在开发用于治疗特定心律失常的曲立帕米,其主要适应症是治疗阵发性室上性心动过速,或PSVT,随后的适应症是治疗具有快速心室率的心房颤动,或AFIB-RVR。
发行价格:
--
{"stockData":{"symbol":"MIST","market":"US","secType":"STK","nameCN":"Milestone Pharmaceuticals Inc.","latestPrice":1.55,"timestamp":1721246400000,"preClose":1.65,"halted":0,"volume":351324,"delay":0,"floatShares":49501400,"shares":53260467,"eps":-1.233081,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.1,"latestTime":"07-18 05:24:48 EDT","open":1.69,"high":1.7,"low":1.48,"amount":560163.3170724,"amplitude":0.133333,"askPrice":2.04,"askSize":200,"bidPrice":1.31,"bidSize":265,"shortable":0,"etf":0,"ttmEps":-1.233081,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721309400000},"adr":0,"listingDate":1557374400000,"adjPreClose":1.55,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.55,"latestTime":"19:55 EDT","volume":730,"amount":1141.13,"timestamp":1721260502311},"volumeRatio":2.614126776368824,"impliedVol":1.3302,"impliedVolPercentile":0.4582},"requestUrl":"/m/hq/s/MIST","defaultTab":"news","newsList":[{"id":"2452456168","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌6.06%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452456168","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452456168?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:19","pubTimestamp":1721225987,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时19分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速下跌6.06%。截至发稿,该股报1.55美元/股,成交量19.2641万股,换手率0.36%,振幅7.88%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为1.08%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717221947af92cb3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717221947af92cb3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2452912117","title":"Milestone Pharmaceuticals Inc.盘中异动 临近午盘大幅拉升5.36%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452912117","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452912117?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:58","pubTimestamp":1721145506,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时58分,Milestone Pharmaceuticals Inc.股票出现波动,股价大幅拉升5.36%。截至发稿,该股报1.67美元/股,成交量3.3628万股,换手率0.06%,振幅2.59%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716235826aef9f798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716235826aef9f798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2450506074","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨6.62%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450506074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450506074?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:12","pubTimestamp":1720552367,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时12分,Milestone Pharmaceuticals Inc.股票出现波动,股价大幅拉升6.62%。截至发稿,该股报1.45美元/股,成交量12.5588万股,换手率0.24%,振幅6.62%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.85%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100312489681b35b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100312489681b35b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2439571000","title":"Milestone Pharmaceuticals Inc.盘中异动 临近午盘快速跳水6.05%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439571000","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439571000?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:32","pubTimestamp":1716996732,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时32分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速跳水6.05%。截至发稿,该股报1.55美元/股,成交量31.6433万股,换手率0.59%,振幅8.48%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为1.03%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529233212aef2593e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529233212aef2593e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2433947081","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433947081","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433947081?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:36","pubTimestamp":1715006179,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时36分,Milestone Pharmaceuticals Inc.股票出现波动,股价急速上涨5.30%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Tc Biopharm Plc、Jasper Therapeutics Inc C/Wts 24/09/2026 、Nrx Pharmaceuticals, Inc.涨幅较大,Tc Biopharm Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃,换手率分别为1049.53%、693.08%、61.73%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Tc Biopharm Plc、Nrx Pharmaceuticals, Inc.,振幅分别为95.51%、84.25%、40.00%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622361979260f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622361979260f26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2432586394","title":"Milestone Pharmaceuticals Inc.盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432586394","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432586394?lang=zh_cn&edition=full","pubTime":"2024-05-01 03:22","pubTimestamp":1714504970,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日03时22分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速上涨5.03%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Eliem Therapeutics, Inc、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大,Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为1553.76%、238.89%、31.37%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 ,振幅分别为60.76%、55.38%、48.00%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010322517a57ca70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010322517a57ca70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2431898407","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨5.50%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431898407","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431898407?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:00","pubTimestamp":1714402816,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时00分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅拉升5.50%。截至发稿,该股报1.62美元/股,成交量2.2292万股,换手率0.04%,振幅5.62%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923001687e84c73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923001687e84c73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2429141283","title":"Milestone Pharmaceuticals Inc.盘中异动 急速上涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429141283","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429141283?lang=zh_cn&edition=full","pubTime":"2024-04-24 03:30","pubTimestamp":1713900610,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日03时30分,Milestone Pharmaceuticals Inc.股票出现波动,股价快速上涨5.27%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为1.64%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 、Abvc Biopharma, Inc.涨幅较大,Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃,换手率分别为2722.73%、182.36%、63.97%,振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为100.59%、80.08%、66.15%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240330107a54f574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240330107a54f574&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2428545383","title":"Milestone Pharmaceuticals Inc.盘中异动 下午盘急速下挫5.14%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428545383","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428545383?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:13","pubTimestamp":1713463993,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时13分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速跳水5.14%。截至发稿,该股报1.66美元/股,成交量7.8418万股,换手率0.15%,振幅5.14%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.72%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419021313792196f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419021313792196f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2426488441","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.49%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426488441","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426488441?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:48","pubTimestamp":1712681284,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日00时48分,Milestone Pharmaceuticals Inc.股票出现异动,股价急速下挫5.49%。截至发稿,该股报1.72美元/股,成交量10.6187万股,换手率0.20%,振幅5.49%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041000480487e7eeb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041000480487e7eeb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2422764472","title":"Milestone Pharmaceuticals Inc.盘中异动 下午盘股价大涨5.20%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422764472","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422764472?lang=zh_cn&edition=full","pubTime":"2024-03-27 01:21","pubTimestamp":1711473705,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日01时21分,Milestone Pharmaceuticals Inc.股票出现波动,股价大幅上涨5.20%。截至发稿,该股报1.82美元/股,成交量11.0334万股,换手率0.21%,振幅6.94%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270121457a4f3a2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270121457a4f3a2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2421684647","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421684647","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421684647?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:33","pubTimestamp":1711121638,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时33分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅上涨5.13%。截至发稿,该股报1.64美元/股,成交量5.221万股,换手率0.10%,振幅3.85%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223335887e7b191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223335887e7b191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2421850188","title":"Milestone Pharmaceuticals Inc.2023财年实现净利润-59.69百万美元,同比减少2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421850188","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421850188?lang=zh_cn&edition=full","pubTime":"2024-03-22 15:19","pubTimestamp":1711091987,"startTime":"0","endTime":"0","summary":"12月31日,Milestone Pharmaceuticals Inc.公布财报,公告显示公司2023财年净利润为-59.69百万美元,同比减少2.23%;其中营业收入为1000000.00美元,同比减少80.00%,每股基本收益为-1.39美元。机构评级:截至2023年12月31日,当前有4家机构对Milestone Pharmaceuticals Inc.目标价做出预测,其中目标均价为10.50美元,其中最低目标价为3.00美元,最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221546468b549a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221546468b549a70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST"],"gpt_icon":0},{"id":"2419398216","title":"Milestone Pharmaceuticals Inc.盘中异动 急速下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419398216","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419398216?lang=zh_cn&edition=full","pubTime":"2024-03-15 00:35","pubTimestamp":1710434123,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日00时35分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速下跌5.52%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、知临集团、Psyence Biomedical Ltd.涨幅较大,知临集团、Novabay Pharmaceuticals, Inc.、Psyence Biomedical Ltd.较为活跃,换手率分别为762.07%、175.28%、104.97%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团,振幅分别为110.40%、80.77%、76.91%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150035247a4cbda3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150035247a4cbda3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2417297854","title":"Milestone Pharmaceuticals Inc.盘中异动 大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417297854","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417297854?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:40","pubTimestamp":1709736034,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时40分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速上涨5.06%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Biomx Inc.、知临集团、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Creative Medical Technology Holdings, Inc.、Biomx Inc.、知临集团较为活跃,换手率分别为169.62%、143.48%、114.31%,振幅较大的相关个股有Biomx Inc.、知临集团、Nkgen Biotech, Inc.,振幅分别为90.44%、65.51%、31.32%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062240347a4a1e3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062240347a4a1e3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2415788540","title":"Milestone Pharmaceuticals Inc.股价重挫23.00% 市值跌1262.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415788540","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415788540?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:32","pubTimestamp":1709217163,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时32分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速跳水23.00%。截至发稿,该股报1.64美元/股,成交量75.0352万股,换手率2.24%,振幅4.69%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.31%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292232438af0be72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292232438af0be72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2414388962","title":"Milestone Pharmaceuticals Inc盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414388962","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414388962?lang=zh_cn&edition=full","pubTime":"2024-02-28 01:07","pubTimestamp":1709053620,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日01时07分,Milestone Pharmaceuticals Inc股票出现波动,股价大幅上涨5.21%。截至发稿,该股报2.22美元/股,成交量20.5809万股,换手率0.61%,振幅5.21%。Milestone Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.12%。Milestone Pharmaceuticals Inc公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022801070087e73a71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022801070087e73a71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2414382378","title":"Milestone Pharmaceuticals Inc盘中异动 早盘大幅上涨21.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414382378","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414382378?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:31","pubTimestamp":1708957915,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时31分,Milestone Pharmaceuticals Inc股票出现波动,股价快速拉升21.76%。Milestone Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,Zyversa Therapeutics Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Immunitybio Inc涨幅较大,Zyversa Therapeutics Inc、Lixte Biotechnology Holdings Inc、Neubase Therapeutics Inc较为活跃,换手率分别为601.65%、57.12%、44.86%,振幅较大的相关个股有Sol Gel Technologies Ltd、Portage Biotech Inc、Ocean Biomedical Inc,振幅分别为22.60%、15.40%、15.29%。Milestone Pharmaceuticals Inc公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262231558ae243b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262231558ae243b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCEA","BK4139","MIST"],"gpt_icon":0},{"id":"2413424173","title":"Milestone Pharmaceuticals Inc盘中异动 早盘急速拉升6.21%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413424173","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413424173?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:43","pubTimestamp":1708526618,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时43分,Milestone Pharmaceuticals Inc股票出现波动,股价大幅上涨6.21%。截至发稿,该股报1.59美元/股,成交量2.3578万股,换手率0.07%,振幅2.00%。Milestone Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.05%。Milestone Pharmaceuticals Inc公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022122433987e71e4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022122433987e71e4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2411652595","title":"Milestone Pharmaceuticals Inc盘中异动 快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411652595","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411652595?lang=zh_cn&edition=full","pubTime":"2024-02-16 01:04","pubTimestamp":1708016693,"startTime":"0","endTime":"0","summary":"北京时间2024年02月16日01时04分,Milestone Pharmaceuticals Inc股票出现波动,股价大幅拉升5.26%。Milestone Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Tc Biopharm Plc C/Wts 10/02/2028 、Hepion Pharmaceuticals Inc涨幅较大,Kintara Therapeutics Inc、Adial Pharmaceuticals Inc、Transcode Therapeutics Inc较为活跃,换手率分别为76.17%、51.22%、28.11%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ,振幅分别为73.10%、67.27%、63.33%。Milestone Pharmaceuticals Inc公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402160104537a43d68d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402160104537a43d68d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.milestonepharma.com","stockEarnings":[{"period":"1week","weight":0.0668},{"period":"1month","weight":0.1151},{"period":"3month","weight":-0.0491},{"period":"6month","weight":0.1071},{"period":"1year","weight":-0.5373},{"period":"ytd","weight":-0.0719}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Milestone Pharmaceuticals Inc.于2003年根据魁北克省法律注册成立。该公司是一家专注于心血管创新药物开发和商业化的生物制药公司。公司主导候选产品曲立帕米是一种新型强效钙通道阻滞剂,他们将其设计为一种快速起效的鼻腔喷雾剂,供患者自行给药。该公司正在开发用于治疗特定心律失常的曲立帕米,其主要适应症是治疗阵发性室上性心动过速,或PSVT,随后的适应症是治疗具有快速心室率的心房颤动,或AFIB-RVR。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.084125},{"month":2,"riseRate":0.2,"avgChangeRate":-0.107485},{"month":3,"riseRate":0.6,"avgChangeRate":-0.097718},{"month":4,"riseRate":0.6,"avgChangeRate":0.105379},{"month":5,"riseRate":0.6,"avgChangeRate":-0.015932},{"month":6,"riseRate":0.5,"avgChangeRate":0.019419},{"month":7,"riseRate":0.833333,"avgChangeRate":0.242265},{"month":8,"riseRate":0.6,"avgChangeRate":0.068353},{"month":9,"riseRate":0.4,"avgChangeRate":-0.014087},{"month":10,"riseRate":0.2,"avgChangeRate":-0.16576},{"month":11,"riseRate":0.4,"avgChangeRate":0.05979},{"month":12,"riseRate":0.2,"avgChangeRate":-0.109404}],"exchange":"NASDAQ","name":"Milestone Pharmaceuticals Inc.","nameEN":"Milestone Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Milestone Pharmaceuticals Inc.,MIST,Milestone Pharmaceuticals Inc.股票,Milestone Pharmaceuticals Inc.股票老虎,Milestone Pharmaceuticals Inc.股票老虎国际,Milestone Pharmaceuticals Inc.行情,Milestone Pharmaceuticals Inc.股票行情,Milestone Pharmaceuticals Inc.股价,Milestone Pharmaceuticals Inc.股市,Milestone Pharmaceuticals Inc.股票价格,Milestone Pharmaceuticals Inc.股票交易,Milestone Pharmaceuticals Inc.股票购买,Milestone Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}